Teva gets FDA clearance for QVAR RediHaler

12:52 EDT 7 Aug 2017 | Drug Store News
The QVAR RediHaler is a breath-actuated inhaler for the maintenance of asthma as a prophylactic treatment in patients ages 4 years and older.

read more

Original Article: Teva gets FDA clearance for QVAR RediHaler


More From BioPortfolio on "Teva gets FDA clearance for QVAR RediHaler"

Quick Search

Relevant Topics

Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...